PCVX
Vaxcyte, Inc.
Clinical-stage vaccine company developing conjugate and novel protein vaccines
CUSIP: 92243G108HealthcareUS1 holder
Total Value
$62.48M
Total Shares
1.35M
Net Share Change
+64.7K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$62.48M1.35M shares
ADD+64.7K(+5.0%)